- Home
- MDXG vs BCSF Comparison
MDXG vs BCSF Comparison
Compare MDXG & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDXG | BCSF |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 901.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MDXG | BCSF |
|---|---|---|
| Price | $6.47 | $13.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.00 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 797.9K | 442.1K |
| Earning Date | 02-25-2026 | 11-10-2025 |
| Dividend Yield | N/A | ★ 12.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.27 | ★ 1.44 |
| Revenue | ★ $393,442,000.00 | $278,347,000.00 |
| Revenue This Year | $19.13 | N/A |
| Revenue Next Year | $2.11 | N/A |
| P/E Ratio | $23.99 | ★ $9.71 |
| Revenue Growth | ★ 14.77 | N/A |
| 52 Week Low | $5.79 | $13.20 |
| 52 Week High | $9.71 | $19.21 |
Technical Indicators
Market Signals| Indicator | MDXG | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 35.33 | 47.81 |
| Support Level | $6.74 | $13.80 |
| Resistance Level | $7.13 | $14.14 |
| Average True Range (ATR) | 0.23 | 0.25 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 0.00 | 29.52 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.